5 Key Takeaways

• 1

  Metabolic acidosis is a common complication in chronic kidney disease, affecting 44% of patients in a Japanese study.

• 2

  Serum bicarbonate measurements were conducted in only 8% to 9% of chronic kidney disease patients annually from 2014 to 2021.

• 3

  Diagnosis and treatment rates for metabolic acidosis were low, with only 9% diagnosed and 8% treated across all stages.

• 4

  Prevalence of metabolic acidosis increased with disease severity, affecting 32% in G3a, 46% in G3b, and 66% in G4.

• 5

  The study highlights the need for improved assessment and management of metabolic acidosis in chronic kidney disease patients in Japan.